Tags » Lifescience

Maximizing profits and patient outcomes during times of dwindling reimbursements

Shrinking professional services reimbursements from all insurance companies is a fact that all practices are facing. With patient footfalls falling and operating costs skyrocketing; there is a need for everyone to look at ways by which to generate additional revenue opportunities with their existing patient base and at the same time, maximize patient clinical outcomes. 402 more words

MEDICAL DEVICE

Glucocorticoid Induced Tumor Necrosis Factor Receptor Market Global Analysis & 2016 Forecast Report

Summary

Publisher’s, ‘Glucocorticoid Induced Tumor Necrosis Factor Receptor (Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) – Pipeline Review, H1 2016’, provides in depth analysis on Glucocorticoid Induced Tumor Necrosis Factor Receptor (Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) targeted pipeline therapeutics. 734 more words

Focal Adhesion Kinase Market Shares, Strategies, and Forecasts, Worldwide, 2016

Focal Adhesion Kinase (FAK or EC 2.7.10.2) – Pipeline Review, H2 2016

Report Summary

Publisher’s, ‘Focal Adhesion Kinase (FAK or EC 2.7.10.2) – Pipeline Review, H2 2016’, provides in depth analysis on Focal Adhesion Kinase (FAK or EC 2.7.10.2) targeted pipeline therapeutics. 599 more words

Comprehensive Information & Analysis Report on Fibroblast Growth Factor Receptor 4 Market - 2016

Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) – Pipeline Review, H2 2016

Report Summary

Publisher’s, ‘Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) – Pipeline Review, H2 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) targeted pipeline therapeutics. 629 more words

Fibroblast Growth Factor Receptor 2 Market – Global Industry Perspective, Comprehensive Analysis and Forecast, 2016

Summary

Publisher’s, ‘Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) – Pipeline Review, H1 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) targeted pipeline therapeutics. 718 more words

Fibroblast Growth Factor Receptor 1 Industry Market Share, Size, Forecast and Trends by 2016

Summary

Publisher’s, ‘Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) – Pipeline Review, H1 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) targeted pipeline therapeutics. 793 more words